Characteristics of 1555 childhood-onset lupus in three groups based on distinct time intervals to disease diagnosis: a Brazilian multicenter study

Imagem de Miniatura
Arquivos
art_V_Characteristics_of_1555_childhoodonset_lupus_in_three_groups_2018.PDF (95.9 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Autores
SAKAMOTO, A. P.
TERRERI, M. T.
SAAD-MAGALHAES, C.
LEN, C. A.
Citação
LUPUS, v.27, n.10, p.1712-1717, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective The objective of this study was to compare demographic data, clinical/laboratorial features and disease activity at diagnosis in three different groups with distinct time intervals between onset of signs/symptoms and disease diagnosis. Methods A multicenter study was performed in 1555 childhood-onset systemic lupus erythematosus (American College of Rheumatology criteria) patients from 27 pediatric rheumatology services. Patients were divided into three childhood-onset systemic lupus erythematosus groups: A: short time interval to diagnosis (<1 month); B: intermediate time interval (1 and <3 months); and C: long time interval (3 months). An investigator meeting was held to define the protocol. Demographic data, SLICC classification criteria and SLEDAI-2K were evaluated. Results The number of patients in each group was: A=60 (4%); B=522 (33.5%); and C=973 (62.5%). The median age at diagnosis (11.1 (4.2-17) vs. 12 (1.9-17.7) vs. 12.5 (3-18) years, P=0.025) was significantly lower in group A compared with groups B and C. The median number of diagnostic criteria according to SLICC (7 (4-12) vs. 6 (4-13) vs. 6 (4-12), P<0.0001) and SLEDAI-2K (18 (6-57) vs. 16 (2-63) vs. 13 (1-49), P<0.0001) were significantly higher in group A than the other two groups. The frequency of oral ulcers in the palate (25% vs. 15% vs. 11%, P=0.003), pleuritis (25% vs. 24% vs. 14%, P<0.0001), nephritis (52% vs. 47% vs. 40%, P=0.009), neuropsychiatric manifestations (22% vs. 13% vs. 10%, P=0.008), thrombocytopenia (32% vs. 18% vs. 19%, P=0.037), leucopenia/lymphopenia (65% vs. 46% vs. 40%, P<0.0001) and anti-dsDNA antibodies (79% vs. 66% vs. 61%, P=0.01) were significantly higher in group A compared with the other groups. In contrast, group C had a less severe disease characterized by higher frequencies of synovitis (61% vs. 66% vs. 71%, P=0.032) and lower frequencies of serositis (37% vs. 33% vs. 25%, P=0.002), proteinuria >500mg/day (48% vs. 45% vs. 36%, P=0.002) and low complement levels (81% vs. 81% vs. 71%, P<0.0001) compared with groups A or B. Conclusions Our large Brazilian multicenter study demonstrated that for most childhood-onset systemic lupus erythematosus patients, diagnosis is delayed probably due to mild disease onset. Conversely, the minority has a very short time interval to diagnosis and a presentation with a more severe and active multisystemic condition.
Palavras-chave
Childhood-onset systemic lupus erythematosus, diagnosis, disease damage and disease activity
URI
https://observatorio.fm.usp.br/handle/OPI/27978
Referências
  1. Ardoin SP, 2012, NAT REV RHEUMATOL, V8, P444, DOI 10.1038/nrrheum.2012.109
  2. Bader-Meunier B, 2005, J PEDIATR-US, V146, P648, DOI 10.1016/j.peds.12.045
  3. Barsalou J, 2013, CURR OPIN RHEUMATOL, V25, P616, DOI 10.1097/BOR.0b013e328363e868
  4. Fonseca AR, 2015, RHEUMATOLOGY, V54, P241, DOI 10.1093/rheumatology/keu278
  5. Gladman DD, 2002, J RHEUMATOL, V29, P288
  6. Gomes RC, 2016, ARTHRIT CARE RES, V68, P1736, DOI 10.1002/acr.22881
  7. Gormezano NWS, 2017, LUPUS, V26, P426, DOI 10.1177/0961203316676379
  8. Gormezano NWS, 2016, SEMIN ARTHRITIS RHEU, V45, P706, DOI 10.1016/j.semarthrit.2015.10.015
  9. Gormezano NWS, 2015, PEDIATR INFECT DIS J, V34, P905, DOI 10.1097/INF.0000000000000756
  10. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  11. Klumb EM, 2015, REV BRAS REUMATOL, V55, P1, DOI 10.1016/j.rbr.2014.09.008
  12. Lube GE, 2016, PEDIATR BLOOD CANCER, V63, P1238, DOI 10.1002/pbc.25976
  13. Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473
  14. Sakamoto AP, 2016, RHEUMATOL INT, V36, P1641, DOI 10.1007/s00296-016-3564-6
  15. Shapiro C, 2007, J RHEUMATOL, V34, P1913
  16. Silva CA, 2012, ARTHRIT CARE RES, V64, P1787, DOI 10.1002/acr.21757
  17. Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P907, DOI 10.1080/1744666X.2016.1195685
  18. Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P301, DOI 10.1586/1744666X.2016.1123621
  19. Zulian F, 2008, LUPUS, V17, P780, DOI 10.1177/0961203308090992

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - LIM/36